Inmode Ltd
Open
SectorHealthcare
13.38 -0.67
Overview
Share price change
24h
Min
13.3
Max
13.53
Income | -15M 12M |
|---|---|
Sales | -22M 82M |
P/E Sector Avg | 10.052 49.712 |
EPS | 0.25 |
Profit margin | 14.097 |
Employees | 660 |
EBITDA | -17M 15M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +16.75% upside |
Next Earnings | 29 lip 2026 |
|---|
Market Cap | -81M 825M |
|---|---|
Previous open | 14.05 |
Previous close | 13.38 |
News Sentiment
By Acuity
50%
50%
155 / 342 Ranking in Healthcare
Inmode Ltd Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Inmode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.